Literature DB >> 6848406

Effect of litholytic bile acids on cholesterol absorption in gallstone patients.

N F LaRusso, J L Thistle.   

Abstract

We measured intestinal absorption of cholesterol by a plasma isotope ratio method and determined biliary bile acid and lipid composition of fasting gallbladder bile in 5 gallstone patients before therapy and during two randomized treatment periods with chenodeoxycholic or ursodeoxycholic acid (13 mg/kg . day). During chenodeoxycholic acid ingestion, biliary bile acids were composed predominantly (84%) of conjugates of chenodeoxycholic acid. During ursodeoxycholic acid administration, conjugates of ursodeoxycholic acid constituted half the bile acid pool (49%). Fasting gallbladder bile was supersaturated in cholesterol before treatment, but became unsaturated during administration of both chenodeoxycholic and ursodeoxycholic acids. In spite of these marked changes in biliary bile acid and lipid composition, cholesterol absorption was not significantly different before (45.4 +/- 4.3%, mean +/- SEM) or after chenodeoxycholic (42.7 +/- 5.1%) or ursodeoxycholic (46.8 +/- 3.7%) acid ingestion. We conclude that chenodeoxycholic and ursodeoxycholic acids unsaturate bile in cholesterol and dissolve gallstones by a mechanism other than the suppression of intestinal absorption of cholesterol.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6848406

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Cholesterol absorption and sterol balance in normal subjects receiving dietary fiber or ursodeoxycholic acid.

Authors:  G Salvioli; R Lugli; J M Pradelli
Journal:  Dig Dis Sci       Date:  1985-04       Impact factor: 3.199

2.  Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients.

Authors:  A Colecchia; G Mazzella; L Sandri; F Azzaroli; M Magliuolo; P Simoni; M L Bacchi-Reggiani; E Roda; D Festi
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

3.  Cholesterol esterase activity of human intestinal mucosa.

Authors:  M Ponz de Leon; F Carubbi; P Di Donato; N Carulli
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

Review 4.  Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

5.  Effect of 7-methylated bile acids and bile alcohols on cholesterol metabolism in hamsters.

Authors:  N Matoba; S Kuroki; B I Cohen; E H Mosbach; C K McSherry
Journal:  Lipids       Date:  1988-05       Impact factor: 1.880

6.  Effects of acute changes of bile acid pool composition on biliary lipid secretion.

Authors:  N Carulli; P Loria; M Bertolotti; M Ponz de Leon; D Menozzi; G Medici; I Piccagli
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

7.  Effect of taurochenodeoxycholate or tauroursodeoxycholate upon biliary output of phospholipids and plasma-membrane enzymes, and the extent of cell damage, in isolated perfused rat livers.

Authors:  S G Barnwell; P J Lowe; R Coleman
Journal:  Biochem J       Date:  1983-10-15       Impact factor: 3.857

Review 8.  Colon cancer checks in when bile acids check out: the bile acid-nuclear receptor axis in colon cancer.

Authors:  Qin Tang; Ronald M Evans
Journal:  Essays Biochem       Date:  2021-12-17       Impact factor: 8.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.